Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Hartford Financial Services Group | HIG | Nov 20, 2024 | 118.21 | +1.19 |
Hartford Multifactor Developed Markets (ex-US) ETF | RODM | Nov 20, 2024 | 29.36 | -0.10 |
Harvard Bioscience | HBIO | Nov 20, 2024 | 2.16 | +5.37 |
Hasbro | HAS | Nov 20, 2024 | 61.85 | +0.15 |
Haverty Furniture Companies | HVT-A | Nov 20, 2024 | 22.27 | 0.00 |
Haverty Furniture Companies | HVT | Nov 20, 2024 | 22.60 | -1.09 |
Hawaiian Electric Industries | HE | Nov 20, 2024 | 10.47 | -1.04 |
Hawkins | HWKN | Nov 20, 2024 | 127.18 | +0.70 |
Hawthorn Bancshares | HWBK | Nov 20, 2024 | 30.60 | -9.12 |
Haymaker Acquisition 4 | HYAC | Nov 20, 2024 | 10.76 | +0.00 |
Haynes International | HAYN | Nov 20, 2024 | 60.99 | +0.03 |
Hayward | HAYW | Nov 20, 2024 | 15.75 | -1.13 |
HBT Financial | HBT | Nov 20, 2024 | 23.62 | -1.01 |
HCA Healthcare | HCA | Nov 20, 2024 | 333.00 | -0.63 |
HCI Group | HCI | Nov 20, 2024 | 108.00 | -1.53 |
HCM II Acquisition | HONDU | Nov 20, 2024 | 10.17 | 0.00 |
HCM II Acquisition | HOND | Nov 20, 2024 | 10.00 | 0.00 |
HCW Biologics | HCWB | Nov 20, 2024 | 0.95 | -13.89 |
HDFC Bank ADR | HDB | Nov 20, 2024 | 63.32 | +0.27 |
Health Catalyst | HCAT | Nov 20, 2024 | 7.36 | -2.39 |
Healthcare AI Acquisition A | HAIA | Nov 20, 2024 | 11.53 | 0.00 |
Healthcare Alphadex First Trust | FXH | Nov 20, 2024 | 107.98 | +1.20 |
Healthcare Bull 3X Direxion | CURE | Nov 20, 2024 | 104.18 | +3.82 |
Healthcare ETF Vanguard | VHT | Nov 20, 2024 | 263.01 | +1.06 |
Healthcare Realty Trust | HR | Nov 20, 2024 | 17.56 | -0.57 |
Healthcare Select Sector SPDR | XLV | Nov 20, 2024 | 142.88 | +1.18 |
Healthcare Services Group | HCSG | Nov 20, 2024 | 11.39 | +0.26 |
Healthcare Triangle | HCTI | Nov 20, 2024 | 1.15 | +1.77 |
HealthEquity | HQY | Nov 20, 2024 | 102.96 | +0.28 |
Healthpeak Properties | DOC | Nov 20, 2024 | 21.43 | +0.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.